Grace Therapeutics GRCE
NASDAQ GRCE
$2.19 +0.05 (+2.35%)
As of: Aug 21, 2026 · 2:23 PM EDT

Grace Therapeutics (GRCE) Gross Margin (QoQ) (2021)

Grace Therapeutics (GRCE) Gross Margin (QoQ) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.81 Bn 130.96 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.07 Bn 78.08 Bn 3.93 Bn
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn
4 Moderna 55.64 Bn 50.50 Bn 52.00 Mn
5 BeOne Medicines 41.99 Bn 36.89 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.68 Bn 28.37 Bn 992.69 Mn
7 BioNTech SE 27.69 Bn 9.29 Bn 668.28 Mn
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.36 Bn 26.52 Bn -
10 Grace Therapeutics 37.82 Mn 37.82 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 966.00